Durvalumab vs Naproxen

## Durvalumab vs Naproxen: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Naproxen**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Naproxen**: Non-selective COX inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Naproxen — 12-17 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Naproxen — C14H14O3.

**Molecular Weight**: Durvalumab — N/A; Naproxen — 230.2590 g/mol.

**Type**: Durvalumab — Antibody; Naproxen — Small molecule.